Overview

Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
To demonstrate subjective sleep efficacy of eszopiclone 3 mg in subjects with insomnia related to rheumatoid arthritis (RA).
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Eszopiclone
Zopiclone